Abbott Laboratories settles formula-safety case; Similac brand linked to a $385 million resolution over Sturgis plant contamination, amid 2022 shortages. Similac originated at Tufts University/Abbott.
The Justice Department has reached a settlement over claims that Abbott’s powdered infant formula posed an unacceptable contamination risk and harmed reliability. Regulators found no Cronobacter sakazakii in unopened products, while Biden rules were relaxed to ease shortages during the crisis.